Celogen Pharma Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2005.
2005 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Celogen Pharma Private Limited

Celogen Pharma Private Limited, a active private limited company, was established on 13 April 2005 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230MH2005PTC152619. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.81 Cr.

It upholds a compliant status. Employing 27 professional, Its leadership includes Rabi Narayan Nayak (Additional Director), Vinod Balramsingh Marwaha (Director), Rajivkumar Janardanprasad Singh (Additional Director). Past directors included Rabi Narayan Nayak, Lakshmikanta Panda, Vinod Balramsingh Marwaha. It holds ₹41.69 Cr open charges and ₹44.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B - 106, Techno City, X 4/1 Ttc Area, Midc, Mahape, Navi Mumbai, Maharashtra, 400705.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2005PTC152619

  • Registration Number

    152619

  • Incorporation Date

    13 April 2005

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.81 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.81 Cr
  • Company Age 21 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 41.69 Cr
  • Satisfied Charges ₹ 44.83 Cr
  • Revenue Growth **** -17.40%
  • Profit Growth **** -0.07%
  • Ebitda **** -27.09%
  • Net Worth 25.52%
  • Total Assets **** 13.87%
Company report

Celogen Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Celogen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Celogen Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rabi Narayan Nayak Additional Director 28 May 2025 Current
Vinod Balramsingh Marwaha Director 01 May 2024 Current
Rajivkumar Janardanprasad Singh Additional Director 30 Apr 2025 Current
Thykoottathil Rajan Matthews Director 27 Apr 2005 Current
Vijaykumar Vazakttuvaliya Raghavan Nair Director 02 Jul 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Aug 2024 Past
Pramod Abcsdd Additional Director 23 Aug 2023 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Managing Director 23 Aug 2023 Past
Pramod Abcsdd Director 31 Mar 2008 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Celogen Pharma.

Celogen Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.4% decrease. The company also saw a slight decrease in profitability, with a 0.07% decrease in profit. The company's net worth Soared by an impressive increase of 25.52%.

Celogen Pharma revenue growth over time
Celogen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.40%
*******
*******
*******
*******
Revenue from Operations
*******
 -19.31%
*******
*******
*******
*******
Total Assets
*******
 13.87%
*******
*******
*******
*******
Profit or Loss
*******
 -0.07%
*******
*******
*******
*******
Net Worth
*******
 25.52%
*******
*******
*******
*******
EBITDA
*******
 -27.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Celogen Pharma?

In 2023, Celogen Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary, 1 Joint Venture and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹416,900,000.00

Satisfied Charges

₹448,300,000.00

Charges Breakdown by Lending Institutions
  • Others : 41.69 Cr
Latest Charge Details
Date Lender Amount Status
26 Nov 2024 Others ₹41.69 Cr Open
24 Nov 2020 Abhyudaya Co-Operative Bank Limited ₹1.50 Cr Satisfied
19 Oct 2020 Abhyudaya Co-Operative Bank Limited ₹3.00 Cr Satisfied
27 Aug 2020 Abhyudaya Co-Operative Bank Limited ₹1.00 Cr Satisfied
16 Mar 2020 Abhyudaya Co-Operative Bank Limited ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Celogen Pharma?

Celogen Pharma has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Celogen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celogen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Celogen Pharma
Recent Activity within the Organization
  • Director Appointment

    Rabi Narayan Nayak was appointed as a Additional Director was appointed as a Additional Director on 28 May 2025 & has been associated with this company since 11 months 29 days . was recorded as a recent event.

  • Director Appointment

    Rajivkumar Janardanprasad Singh was appointed as a Additional Director was appointed as a Additional Director on 30 Apr 2025 & has been associated with this company since 1 year 26 days . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 26 Feb 2020 via Charge ID 100327222 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 07 Feb 2025. was documented.

  • Charges

    A charge with Others amounted to Rs. 41.69 Cr with Charge ID 101019713 was registered on 26 Nov 2024. was recorded as a recent event.

  • Annual General Meeting

    Progress on Celogen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Vinod Balramsingh Marwaha was appointed as a Director was appointed as a Director on 01 May 2024 & has been associated with this company since 2 years 25 days . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Celogen Pharma Private Limited?

The CIN of Celogen Pharma Private Limited is U24230MH2005PTC152619.

Where is Celogen Pharma Private Limited headquartered?

Celogen Pharma Private Limited is headquartered at B - 106, Techno City, X 4/1 Ttc Area, Midc, Mahape, Navi Mumbai, Maharashtra, 400705.

When was Celogen Pharma Private Limited incorporated?

Celogen Pharma Private Limited was incorporated on 13 April 2005.

Who are the current directors of Celogen Pharma Private Limited?

The current directors of Celogen Pharma Private Limited are

What is the primary industry of Celogen Pharma Private Limited?

The primary industry of Celogen Pharma Private Limited is Trade.

Is Celogen Pharma Private Limited a listed company?

Celogen Pharma Private Limited is unlisted.

What is the capital structure of Celogen Pharma Private Limited?

The authorized capital of Celogen Pharma Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.81 Cr.

What is the compliance status of Celogen Pharma Private Limited?

The compliance status of Celogen Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available